Insulin

DBCAT000170Therapeutic category

A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is... A DrugBank category of 17 drugs. 10 of them are approved.

Part of: Blood Glucose Lowering Agents
Also known as: Chain, Insulin B · Iletin · Insulin A Chain · Insulin B Chain · Insulin, Regular
Drugs: C-peptide
Insulin argine
Insulin aspart
Insulin beef
Insulin degludec
Insulin detemir
Insulin glargine
Insulin glulisine
Insulin human
Insulin icodec
Insulin lispro
Insulin peglispro
Insulin pork
Insulin tregopil
NN344
Pegylated synthetic human c-peptide
Proinsulin human

What you can answer from here — as of July 06, 2018

17DrugsEach linked to its full drug card

Listed above

7Drug targetsEvery drug–target pair in the class, with bond type

2,283Marketed productsAcross the regions we cover, with dosage forms and routes

10Routes of administrationHow the drugs in this class are given

3SubcategoriesNarrower classes within this one

Which targets do Insulin share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account